Innoviva Inc
NASDAQ:INVA

Watchlist Manager
Innoviva Inc Logo
Innoviva Inc
NASDAQ:INVA
Watchlist
Price: 17.78 USD -0.06% Market Closed
Market Cap: 1.1B USD
Have any thoughts about
Innoviva Inc?
Write Note

Innoviva Inc
Investor Relations

In the heart of Silicon Valley, Innoviva Inc. has carved out a niche within the pharmaceutical landscape, balancing the art of innovation with the demands of modern healthcare economics. Initially emerging as a dynamic player in drug development, Innoviva made a strategic pivot to focus on the monetization and management of its royalties and collaborations. The company's primary revenue stream flows from partnerships with GlaxoSmithKline (GSK), stemming from co-developed respiratory treatments like the inhaled medications Trelegy and Anoro Ellipta. These partnerships provide Innoviva with steady royalty income based on product sales, allowing it to operate with a lean but effective business model, focusing on maximizing value from its existing assets rather than pursuing the expensive and risky path of drug discovery and development.

Beyond merely basking in the comfort of predictable cash flows, Innoviva has tactically reinvested its earnings to fuel further growth and diversification. The company has been channeling resources into acquiring new assets and entering joint ventures that align with its core expertise and long-term vision. This approach not only broadens its portfolio but also hedges against the inherent risks associated with dependency on a limited number of revenue sources. By leveraging its financial strength and strategic partnerships, Innoviva has positioned itself as a nimble player in the pharmaceutical sector, adept at extracting maximum value through prudent financial management and strategic foresight.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Stephen Basso M.B.A.
Chief Financial Officer
No Bio Available
Ms. Patricia M. Drake
Chief Commercial Officer-Innoviva Specialty Therapeutics, Inc.
No Bio Available

Contacts

Address
CALIFORNIA
Burlingame
1350 Old Bayshore Highway, Suite 400
Contacts
+16502389600.0
www.inva.com